Cosyntropin Patent Expiration

Cosyntropin was first introduced by Amphastar Pharmaceuticals Inc in its drug Cortrosyn on Approved Prior to Jan 1, 1982. Another drug containing Cosyntropin is Cosyntropin. 3 different companies have introduced drugs containing Cosyntropin.


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Cosyntropin Generic API Manufacturers

Several generic applications have been filed for Cosyntropin. The first generic version for Cosyntropin was by Pharmobedient Consulting Llc and was approved on Dec 17, 2009. And the latest generic version is by Sandoz Inc and was approved on Jun 29, 2012.

Given below is the list of companies who have filed for Cosyntropin generic, along with the locations of their manufacturing plants worldwide.